( MENAFN - EIN Presswire) Generative Artificial Intelligence (AI) In Pharmaceutical Global market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 9, 2024 /EINPresswire / -- The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only! The generative artificial intelligence AI in the pharmaceutical market has witnessed exponential growth in recent years. It is projected to grow from $1.41 billion in 2023 to a promising $1.85 billion in 2024, showcasing a compound annual growth rate CAGR of 31%. The surge in the previous period can be credited to the expansion in computational power, the prominence of big data in healthcare and pharmaceuticals, booming research and development investment, amplified data quality, and seamless integration and spread of cloud computing. Interested in the Detailed Market Landscape of the Generative Artificial Intelligence AI In Pharmaceutical Sector? The predictive trajectory of the generative AI in the pharmaceutical market suggests exponential growth in the forthcoming years. It is slated to reach a staggering $5.47 billion in 2028, at a compound annual growth rate CAGR of 31.1%. This sustainable growth in the projection period can be linked to a renewed emphasis on early disease detection, robust regulatory support, and guidelines combined with an enhanced computational power, surge in drug development costs, and increased data availability. Notable trends gating the forecast period include a seamless blend of blockchain and AI, advanced data integration, improved disease prognosis, automated drug repurposing, real-time clinical trial optimization. Pre-book the report for a swift delivery: What's Driving the Generative Artificial Intelligence AI In Pharmaceutical Market Growth? An overarching emphasis on personalized medicine is anticipated to boost the market for generative AI in pharmaceuticals. Personalized Medicine customizes medical treatment to the individual traits, requirements, and predilections of patients, leveraging genetic, environmental, and lifestyle factors. The focus on personalized medicine is gathering pace due to advancements in genetic research and technology, enabling more precise and effective treatments individualized for each patient. For instance, in February 2024, a US-based non-profit organization, Personalized Medicine Coalition, relayed that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to a mere six in 2022. Such trends demonstrate the vital role of personalized medicine in driving the growth of generative AI in the pharmaceutical market. Who Are the Top Players Boosting the Generative Artificial Intelligence AI In Pharmaceutical Market? Key global leaders stimulating the generative artificial intelligence AI in pharmaceutical market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., and BenevolentAI Limited. How is Technology Reshaping the Generative Artificial Intelligence AI In Pharmaceutical Landscape? Trendsetting companies operating in the generative AI in pharmaceutical market are venturing into new products, such as AI healthcare microservices, to streamline drug discovery processes. For instance, in March 2024, Nvidia Corporation launched generative AI microservices. These present advanced imaging, natural language, and speech recognition, along with digital biology capabilities, thereby enhancing drug discovery and genomic workflows. How is the Generative Artificial Intelligence AI In Pharmaceutical Market Structured? The generative artificial intelligence AI in the pharmaceutical market report encapsulates the market's segmentation: 1 By Type: Small Molecule, Large Molecule 2 By Technology: Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies 3 By Application: Clinical Trial Research, Drug Discovery, Research And Development, Other Applications Dive Into Detailed Insights of the Global Generative Artificial Intelligence (AI) In Pharmaceutical Market with a Free Sample Report: Regional Dissection of the Generative Artificial Intelligence AI In Pharmaceutical Market North America led the generative artificial intelligence AI in pharmaceutical market in 2023. The encompassed regions in the report comprise Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Browse Through More Similar Reports By The Business Research Company: Generative AI In Gaming Global Market Report 2024 Generative AI Global Market Report 2024 Generative Artificial Intelligence (AI) in Sports Global Market Report 2024 About The Business Research Company Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game. Connect with us at: The Business Research Company: Americas +1 3156230293 Asia +44 2071930708 Europe +44 2071930708 Email us at ... Follow us on: LinkedIn: YouTube: Global Market Model: global-market-model Oliver Guirdham The Business Research Company +44 20 7193 0708 email us here Visit us on social media: Facebook X LinkedIn Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. MENAFN08122024003118003196ID1108969599 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Oklahoma State hired Todd Grantham as its new defensive coordinator, first reported by Pokes Report. The 2025 will mark Grantham’s 35th season in coaching and his 16th as a defensive coordinator, having previously called plays for the Cleveland Browns (2005-07), Georgia (2010-13), Louisville (2014-16), Mississippi State (2017) and Florida (2018-21). Grantham spent the past two seasons with the New Orleans Saints, where he served as the defensive line coach. He was moved to a senior adviser role in early November when Dennis Allen was fired and Darren Rizzi was named interim head coach. He has also coached the defensive line at his alma mater Virginia Tech, Michigan State under Nick Saban, the Indianapolis Colts, Houston Texans and Dallas Cowboys. During his most recent stint as defensive coordinator, the Florida Gators’ defense quickly improved in his first season. In his second season, it finished top 10 in scoring defense (15.5 points per game) and total defense (306.6 yards per game). But the unit took a turn for the worse in his last two seasons. The Gators gave up 30.8 points per game in 2020 – their worst mark in 103 years. Grantham was fired in the middle of the 2021 following a three-game losing streak in which Florida allowed 454 yards to LSU (321 yards rushing), 354 yards to Georgia and 459 yards to South Carolina. Still, he brings a wealth of NFL and high-level Division I experience to a Cowboys defense that ranked 125th in scoring defense and 132nd in total defense under Bryan Nardo.Wade Taylor IV scored 15 points and dished out 10 assists and C.J. Wilcher added 14 points as No. 13 Texas A&M throttled Abilene Christian 92-54 on Saturday afternoon in College Station, Texas. The Aggies (11-2) were in charge from the jump, forging a 19-point lead at halftime and never looking back. Texas A&M scored the first points of the second half, was up by 28 with 13:23 to play and cruised to the finish line while winning its seventh straight game. Taylor's output moved him into second place in the Aggies all-time scoring list. His 1,779 points are now behind only Bernard King, who had 1,990 from 1999-2003. Andersson Garcia and Zhuric Phelps added 12 points each for Texas A&M, which appears to be hitting on all cylinders heading into its Southeastern Conference opener at home against rival Texas on Jan. 4. Phelps added 10 rebounds for the Aggies. Quion Williams led the Wildcats (8-6) with 14 points. Abilene Christian missed its final six shots and went the last 5:24 of the game without a point. The Aggies made a statement in the early going by scoring the game's first nine points over the initial 3 1/2 minutes, with seven of those coming from Coleman. Abilene Christian fought back to within 16-12 after Dontrez Williams' layup with 12:12 left in the half. But A&M swung back, producing a 14-0 run capped by Garcia's layup with 8:51 to play in the half to pull away to a 30-12 advantage. The Wildcats again cut into their deficit, pulling to 30-19 when Cade Hornecker hit a layup with 6:26 to play until halftime. A&M boosted the lead back to 17 points after a pair of free throws by Taylor and got two more from the charity stripe to take a 48-29 edge to the break. Wilcher led all scorers in the half with 12 points on 4-of-6 shooting from beyond the arc while Garcia hit for 10 points for A&M while making all four of his shots from the floor. The Aggies outshot Abilene Christian 61.5 percent to 40.7 percent before halftime. Quion Williams and Leonardo Bettiol paced the Wildcats with seven points each in the first half. --Field Level Media
Lorenz scores 20, Wofford downs Kentucky Christian 100-55Teals MP kingmaker accuses major parties of attempting to ‘rig’ future elections
How much political donors will be able to contribute to campaigns will be capped but the finer details of electoral laws remain elusive despite a rush to pass them. Login or signup to continue reading Individuals would only be able to donate $20,000 and donations above $1000 will have to be disclosed in near real time. But the thresholds aren't set in stone. The Liberals, Nationals and some teal independents are negotiating to increase the donation cap by tens of thousands of dollars - potentially as high as $50,000 - and increase the disclosure limit, with one suggestion to double it to $2000. Increasing the total election spending cap - set at $90 million for political parties and $11 million for special interest groups such as unions and Climate 200 - is also featuring in negotiations ahead of the bill coming before the Senate on Monday. In principle, Labor's legislation is what transparency and reform advocates called for but it's struggling to find friends outside the major parties with independents accusing the government and coalition of a political stitch-up. It's revitalised grassroots supporters with 100 volunteers signing up for independent ACT senator David Pocock's re-election campaign in a single night after the proposed reforms were announced. Extra public cash for candidates to run elections will disproportionately benefit major parties and boost their coffers by millions of dollars not available to independents, crossbenchers argue. Liberals have privately raised concerns about an $800,000 cap per electorate exceeding the $90 million federal cap when all 150 seats are accounted for, meaning the full amount couldn't be spent on each campaign. Despite not all electorates drawing the same expenditure, with major parties putting minimal resources into near-unwinnable seats, there were concerns this could hamper Liberals facing well-resourced independents. Half a dozen Liberals were unseated by teals in 2022. Independents only need to focus on a single seat and can spend up to the cap without worrying about breaching it elsewhere, one Liberal MP said. And while groups such as Climate 200 can spend a lot less than political parties federally, they were targeting fewer seats where advertising could be concentrated, they said. The same argument is being made behind the scenes about minor parties such as the Greens following outcry about the reforms stacking the field for major parties, which Labor disagrees with. But Senator Pocock still questioned whether his history-making victory at the 2022 election could have happened under the reforms due to a mismatch in funds major parties would have had against him. While caps for all Senate candidates are the same - $200,000 per electorate in the state - political parties had their federal war chests they could use to broadly advertise in key seats or states while he would be limited to $600,000. "That's not a level playing field," he said. Senator Pocock and the Greens are likely to vote against the bill in its entirety, arguing there's a lack of scrutiny in the rush to pass a bill that disproportionately helps majors despite it not taking effect until mid-2026, after the next election. The laws are set to start in mid-2026, which would capture the election slated for 2028. Australian Associated Press DAILY Today's top stories curated by our news team. Also includes evening update. WEEKDAYS Grab a quick bite of today's latest news from around the region and the nation. WEEKLY The latest news, results & expert analysis. WEEKDAYS Catch up on the news of the day and unwind with great reading for your evening. WEEKLY Get the editor's insights: what's happening & why it matters. WEEKLY Love footy? We've got all the action covered. WEEKLY Every Saturday and Tuesday, explore destinations deals, tips & travel writing to transport you around the globe. WEEKLY Get the latest property and development news here. WEEKLY Going out or staying in? Find out what's on. WEEKDAYS Sharp. Close to the ground. Digging deep. Your weekday morning newsletter on national affairs, politics and more. WEEKLY Follow the Newcastle Knights in the NRL? Don't miss your weekly Knights update. TWICE WEEKLY Your essential national news digest: all the big issues on Wednesday and great reading every Saturday. WEEKLY Get news, reviews and expert insights every Thursday from CarExpert, ACM's exclusive motoring partner. TWICE WEEKLY Get real, Australia! Let the ACM network's editors and journalists bring you news and views from all over. AS IT HAPPENS Be the first to know when news breaks. DAILY Your digital replica of Today's Paper. Ready to read from 5am! DAILY Test your skills with interactive crosswords, sudoku & trivia. Fresh daily!